Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Expands Shanghai Fast Trak Training Center

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Expansion adds IN Cell, Biacore and DeltaVision technologies for drug discovery and development.

GE Healthcare has announced the official opening of its expanded Fast Trak Training Center in Shanghai, China.

The opening ceremony was hosted by Kieran Murphy, CEO of GE Healthcare Life Sciences, and was attended by leading representatives from academia and the local biopharmaceutical and biotechnology industry.

GE Healthcare’s Fast Trak Training and Education Courses provide hands-on practical training in the latest technologies and strategies for start-to-finish bioprocessing, and are specifically designed to help manufacturers of biopharmaceuticals increase their process productivity and bring their product to market faster.

The company’s Fast Trak Training Centers, which are also located in Germany, India, Japan, Singapore, and the US, are equipped with the latest technologies for bioprocessing, in an environment that closely replicates the industrial setting.

GE Healthcare’s Fast Trak Training & Education team has over 20 years’ experience in providing training for bioprocess development and manufacturing.

By expanding the Fast Trak Center in Shanghai, GE Healthcare will be able to offer an increased number and variety of courses to meet the needs of the rapidly growing biopharmaceutical industry in China.

The extended Center has been equipped with several new GE Healthcare technologies such as IN Cell and DeltaVision™ for cellular imaging and Biacore™ and Microcal™ tools for protein interaction studies, allowing the company to offer, for the first time, training in some of the latest techniques used in drug discovery and development.

In addition to training, the Shanghai Fast Trak Center will also offer a full bioprocess development service to the industry, helping manufacturing professionals develop, optimize and refine their biopharmaceutical manufacturing processes for maximum productivity.

At the opening ceremony Mr Murphy also outlined GE Healthcare’s plans to launch an Educational Outreach Program for local university science students, in order to stimulate and encourage interest in the biopharmaceutical manufacturing industry.

Called Biotech “Future Stars” Training Program, the Outreach Program will be based on standard Fast Trak training courses and will be delivered by GE Healthcare scientists and sector experts.

Mr Murphy said, “I’m delighted to be opening our upgraded and expanded training facility here today. Bigger and better facilities will help us to offer a much higher level of support to the biopharmaceutical industry here in China. The Chinese government has identified the development of the biopharmaceutical industry as one of the pillar industries in the country’s 12th 5 year plan of state, and our new investments here in Shanghai are aligned with that.”

The Fast Trak Center is located within the GE China Technology Center (CTC), an integrated multi-disciplinary research campus with more than 1,500 researchers in over 60 laboratories researching breakthrough technologies in key areas such as energy, materials science and imaging technologies.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences and Promosome Sign Licensing Agreement
Innovative mammalian cell line development technologies that show promise for increasing manufacturing efficiency of vital biopharmaceuticals.
Tuesday, April 29, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
Innovative approach will save biopharmaceutical manufacturers time and money.
Tuesday, January 15, 2013
iBio, Inc. and GE Healthcare Form New Global Alliance
Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture.
Thursday, December 27, 2012
GE Healthcare Offers Fast Trak Training in Singapore
Fast Trak training and education courses provide practical training in the latest technologies and strategies for bioprocessing.
Tuesday, June 05, 2012
Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy
Pioneering three-year study will investigate technology and workflow needs in a clinical setting.
Wednesday, May 23, 2012
GE Healthcare to acquire Xcellerex Inc.
Addition of high growth company builds integrated, start-to-finish industry offering, focused on lowering costs, increasing productivity and reducing time to market.
Thursday, March 08, 2012
GE Healthcare and Neste Jacobs Form Strategic Alliance
Alliance will help healthcare providers worldwide increase access to life-saving treatments.
Tuesday, January 03, 2012
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.
Wednesday, December 14, 2011
NIBRT and GE Healthcare Announce Biopharmaceutical Research Collaboration
Joint research project to drive new technologies for the development and functional analysis of therapeutic antibodies.
Tuesday, October 04, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
G-Con Manufacturing, LLC and GE Healthcare announce their intention to collaborate on the development of a modular portable bio-process manufacturing solution for vaccines and therapeutics.
Friday, December 03, 2010
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!